ImMAGE Biotherapeutics’ DNA immunotherapy shows high efficacy with low toxicology results – PR Newswire (press release)
|
ImMAGE Biotherapeutics' DNA immunotherapy shows high efficacy with low toxicology results
PR Newswire (press release) BETHESDA, Md., March 27, 2017 /PRNewswire-USNewswire/ — ImMAGE Biotherapeutics (OTCMKTS: IMMG), an early-stage biotechnology company, announced today that its immunotherapy successfully passed early toxicology and efficacy studies. |
